Brookfield Business stock hits 52-week high at 30.34 USD

Published 24/06/2025, 14:32
Brookfield Business stock hits 52-week high at 30.34 USD

Brookfield Business stock reached a significant milestone by hitting a 52-week high of 30.34 USD. This achievement underscores the company’s robust performance over the past year, with the stock delivering a 59.22% return. The $2.16 billion market cap company has demonstrated strong momentum, posting a 26.52% gain in the last six months alone. Investors have shown growing confidence in Brookfield Business, as reflected in the stock’s upward trajectory. The 52-week high marks a pivotal point for the company, suggesting strong market position despite operational challenges. InvestingPro analysis reveals the stock is trading above its Fair Value, with additional risks including significant debt burden and weak profit margins. InvestingPro subscribers have access to 10 more key insights about Brookfield Business’s financial health and valuation metrics.

In other recent news, Brookfield Business Corporation reported its financial results for the first quarter of 2025. The company revealed adjusted earnings per share of $0.38, surpassing analyst expectations, although revenue significantly decreased to $6.75 billion from $12.02 billion in the same quarter of the previous year. Despite the revenue drop, the company’s Adjusted EBITDA improved to $591 million, indicating enhanced operational efficiency. Brookfield Business Partners (NYSE:BBU) also announced plans to acquire Antylia Scientific for approximately $1.3 billion, aiming to secure a 25% stake with an investment of about $160 million.

In corporate governance developments, Brookfield Business Corporation successfully elected all ten nominees to its board of directors during its annual general meeting. The voting saw strong support, with approval ratings ranging from 97.22% to 99.97%. Additionally, the company’s SEC filing highlighted its compliance with financial reporting obligations, providing a snapshot of its financial health for the quarter ending March 31, 2025.

These recent developments reflect Brookfield Business Corporation’s ongoing strategic initiatives and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.